Patent · US Active

Modulators of cystic fibrosis transmembrane conductance regulator

US8513282B2 · kind B2 · utility

78Cited by
30References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2009
Grant dateAug 20, 2013
Priority date
Expiry dateMar 4, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/382
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to modulators of cystic fibrosis transmembrane conductance regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating diseases using modulators of CFTR.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.